Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Martin
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
91 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Saint Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital Association
Canton, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Eureka Hospital
Eureka, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Illinois Cancercare-Havana
Havana, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Illinois Cancercare-Kewanee Clinic
Kewanee, Illinois, United States
- Amita Health Adventist Medical Center
La Grange, Illinois, United States
- Illinois Cancercare-Macomb
Macomb, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Holy Family Medical Center
Monmouth, Illinois, United States
- Illinois Cancercare-Monmouth
Monmouth, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Carle Cancer Institute Normal
Normal, Illinois, United States
- Illinois Cancercare-Community Cancer Center
Normal, Illinois, United States
- Illinois Cancercare-Ottawa Clinic
Ottawa, Illinois, United States
- Ottawa Regional Hospital and Healthcare Center
Ottawa, Illinois, United States
- Illinois Cancercare-Pekin
Pekin, Illinois, United States
- Osf Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
Pekin, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Osf Saint Francis Medical Center
Peoria, Illinois, United States
- Proctor Hospital
Peoria, Illinois, United States
- Illinois Cancercare-Peru
Peru, Illinois, United States
- Illinois Valley Hospital
Peru, Illinois, United States
- Illinois Cancercare-Princeton
Princeton, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jun 2010
- Primary completion
- 31 Dec 2012
- Completion
- 15 Jan 2022
- Last update posted
- 27 Jun 2023
- Registered enrollment
- 66
- Registry id
- NCT01145495
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.